Medical Devices; Orthopedic Devices; Classification of the Wearable Vibration Device for Orthopedic Use
By Drug Administration, Human Services Department, Food, Health · Nov 4, 2026, 11:00 PM CST
The Food and Drug Administration (FDA) is classifying the wearable vibration device for orthopedic use into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the wearable vibration device for orthopedic use. We are taking this action because we have determined that classifying
Excerpt shown under fair-use limits. Full text remains with the original publisher.
People in this coverage
Explore their history and attributable record. Being mentioned does not imply endorsement.
Layer 1 · Claims & fact checks
AI analysisLayer 3 · Reporting analysis
AI analysisAgency framingThe FDA frames the classification as a protective measure for safety and effectiveness, positioning the decision as evidence‑based.
Benefit emphasisThe agency highlights anticipated patient benefits and reduced regulatory burden, presenting the classification as a win‑win for innovation and public health.
Context
AI analysisMissing context
The notice does not provide details about the specific special controls, the criteria used to determine Class II status, or any timeline for implementation and compliance by manufacturers.
Important context
Class II designation indicates that the device is subject to special controls in addition to general controls, which typically include performance standards, post‑market surveillance, and labeling requirements. This classification can affect how quickly the device reaches the market and the regulatory obligations of manufacturers.
Opinion vs. reporting
AI analysisThe text is primarily reporting factual regulatory action by the FDA; it contains no overt opinion, only statements of intent and expected outcomes presented as the agency’s rationale.